A Multicenter, Randomized Double-Blinded, Placebo-Controlled, Dose-Ranging, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY3009104 in Pa

Printer-friendly versionSend by emailPDF version

Name

Eli Lilly and Company

Anticipated Amount

132 110.00

Activity Type

Clinical Trial

Award Type

Contract

Date

September 1, 2012 to May 30, 2014

Award Number

005930-00001

Sponsor Award Number

28022

Award Contacts

Name

Szerlip,Harold M

Title

Principal Investigator

Unit

Medicine

UA@Work is produced by University Communications

888 N. Euclid Ave., Ste. 413 (or) 
P.O. Box 210158, Tucson, AZ 85721

T 520.621.1877  F 520.626.4121

Feedback

2018 © The Arizona Board of Regents on behalf of the University of Arizona